News & Analysis as of August 16, 2025

Centers for Medicare & Medicaid Services (CMS)

+ Follow

A repository for the most well-read content on JD Supra at any given time, along with occasional roundups of popular content by specific topic. Also stop by for monthly recaps of hot articles for the previous... more +

How Pharma Should Prep for the Six-bill Avalanche From Congress

Latham & Watkins LLP on 5/1/2025

The bipartisan legislative push could create big hurdles for drug development, with concerns mounting over limited patent protections and increased litigation risks, hears Marisa Woutersen. The US pharmaceutical industry...more

CMS Issues Final 2025 Calendar Year Medicare Physician Fee Schedule Final Rule

King & Spalding on 11/20/2024

On November 1, 2024, CMS issued a rule finalizing changes to Medicare payments under the Physician Fee Schedule (PFS) and other Medicare Part B policies effective on or after January 1, 2025 (the Final Rule). Section 1848 of...more

CMS Issues Updates Regarding ASP: Negative ASP, Radiopharmaceuticals, Restatements, and Skin Substitutes

Hogan Lovells on 7/30/2024

The Centers for Medicare & Medicaid Services (CMS) recently issued several important updates concerning the reporting of Average Sales Price (ASP) with potential implications for manufacturers. ...more

Washington Healthcare Update - February 2023 #3

McGuireWoods Consulting on 2/21/2023

Upcoming Hearings - March 22 - Senate Committee on Health, Education, Labor and Pensions Hearing: “Taxpayers Paid Billions For It: So Why Would Moderna Consider Quadrupling the Price of the COVID Vaccine?” 10:00 a.m.,...more

4 Results

View per page

Page: of 1

Today's Popular Updates › Biosimilars › Centers for Medicare & Medicaid Services (CMS)

How Pharma Should Prep for the Six-bill Avalanche From Congress

CMS Issues Final 2025 Calendar Year Medicare Physician Fee Schedule Final Rule

CMS Issues Updates Regarding ASP: Negative ASP, Radiopharmaceuticals, Restatements, and Skin Substitutes

Washington Healthcare Update - February 2023 #3

"My best business intelligence, in one easy email…"